Management of Neuroblastoma in Pediatric Patients

Abstract

Surgeons caring for patients with neuroblastoma must be familiar with recent developments in assessing risk. In particular, the Children's Oncology Group, along with major international groups, uses the International Neuroblastoma Risk Group Staging System as a risk assessment tool. Accurate risk determination is essential for optimal surgical therapy. Some tumors like neonatal adrenal neuroblastomas and those in the metastatic category can be observed. Very-low-risk and low-risk neuroblastomas can be treated with surgery alone. Intermediate-risk tumors also often require systemic chemotherapy.

Keywords: Local control; Neuroblastoma; Pediatric surgery; Resection; Risk status; Staging; Survival; Treatment.